1.43
전일 마감가:
$1.41
열려 있는:
$1.41
하루 거래량:
21,105
Relative Volume:
0.30
시가총액:
$70.39M
수익:
$409.70K
순이익/손실:
$-12.00M
주가수익비율:
-5.8487
EPS:
-0.2445
순현금흐름:
$-9.81M
1주 성능:
-0.69%
1개월 성능:
+5.93%
6개월 성능:
+15.32%
1년 성능:
+2.14%
Medicinova Inc Stock (MNOV) Company Profile
명칭
Medicinova Inc
전화
858-373-1500
주소
4275 EXECUTIVE SQUARE, LA JOLLA, CA
Compare MNOV vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
MNOV
Medicinova Inc
|
1.43 | 69.40M | 409.70K | -12.00M | -9.81M | -0.2445 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Medicinova Inc Stock (MNOV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-16 | 개시 | H.C. Wainwright | Buy |
| 2021-03-10 | 개시 | Maxim Group | Buy |
| 2019-03-25 | 재개 | B. Riley FBR | Buy |
| 2018-03-28 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-04-18 | 개시 | Credit Suisse | Outperform |
| 2013-01-04 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-05-24 | 다운그레이드 | MLV & Co | Buy → Hold |
| 2011-10-18 | 재확인 | MLV Capital | Buy |
| 2011-06-22 | 개시 | Global Hunter Securities | Buy |
| 2010-05-12 | 개시 | Wedbush | Outperform |
| 2008-11-12 | 재확인 | Ladenburg Thalmann | Buy |
| 2008-05-15 | 개시 | Rodman & Renshaw | Mkt Outperform |
| 2007-07-09 | 개시 | Punk, Ziegel & Co | Buy |
모두보기
Medicinova Inc 주식(MNOV)의 최신 뉴스
Gainers Report: What is the next catalyst for MediciNova IncMarket Sentiment Review & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
D. Boral Capital Maintains MediciNova (MNOV) Buy Recommendation - MSN
MNOV Stock Price, Quote & Chart | MEDICINOVA INC (NASDAQ:MNOV) - ChartMill
Nasdaq Moves: Whats the MACD signal for MediciNova Inc2026 Spike Watch & Breakout Confirmation Trade Signals - baoquankhu1.vn
Fed Meeting: What is the next catalyst for MediciNova IncRecession Risk & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Investor Mood: What analysts say about MediciNova Inc stockSell Signal & Daily Profit Focused Stock Screening - baoquankhu1.vn
Can MediciNova Inc expand its profit marginsQuarterly Growth Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
BYSI PE Ratio & Valuation, Is BYSI Overvalued - Intellectia AI
Sentiment Watch: How sensitive is MediciNova Inc to inflationWeekly Investment Report & Expert Curated Trade Setups - baoquankhu1.vn
Buy Signal: What is the next catalyst for MediciNova IncEarnings Risk Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
Winners Losers: Can MediciNova Inc beat the S P 500Forecast Cut & Precise Swing Trade Alerts - baoquankhu1.vn
Medicinova Inc (NASDAQ:MNOV) Reiterates Buy Rating - FXDailyReport.Com
Maxim Group Maintains MediciNova(MNOV.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Maxim Group Reiterates "Buy" Rating for MediciNova (NASDAQ:MNOV) - MarketBeat
MediciNova, Inc. (NASDAQ:MNOV) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
MediciNova, Inc. (NASDAQ:MNOV) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
MediciNova Inc stock draws attention amid biotech pipeline momentum and analyst upside calls - AD HOC NEWS
MediciNova (NASDAQ:MNOV) Upgraded at Zacks Research - Defense World
MediciNova (NASDAQ:MNOV) Raised to "Hold" at Zacks Research - MarketBeat
What is HC Wainwright’s Estimate for MediciNova Q1 Earnings? - Defense World
Q1 Earnings Estimate for MediciNova Issued By HC Wainwright - MarketBeat
HC Wainwright & Co. initiates coverage of MediciNova (MNOV) with buy recommendation - MSN
Stock Analysis: Can MediciNova Inc continue delivering strong returnsQuarterly Risk Review & Verified Swing Trading Watchlist - baoquankhu1.vn
MediciNova (NASDAQ:MNOV) Now Covered by HC Wainwright - MarketBeat
MediciNova to Participate at the 38th Annual ROTH Conference - Bitget
This Cohu Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
MediciNova Inc Stock (ISIN: US58468P2038) Surges on Clinical Trial Momentum—Analysts See 469% Upsi - AD HOC NEWS
MediciNova, Inc. 2025 Annual Report: Advancing MN-166 and MN-001 Therapies for Neurological and Metabolic Diseases - Minichart
Medicinova 2025 10-K: Revenue $0.41M, EPS $(0.24) - TradingView
MediciNova (NASDAQ: MNOV) highlights MN-166 and MN-001 progress in annual report - Stock Titan
Quarterly Recap: What is the next catalyst for MediciNova IncChart Signals & Fast Moving Trade Plans - baoquankhu1.vn
Trend Review: Is MediciNova Inc a stock for growth or value investorsWeekly Trading Summary & AI Forecasted Stock Moves - baoquankhu1.vn
MediciNova (NASDAQ:MNOV) Stock Passes Above 200-Day Moving AverageShould You Sell? - MarketBeat
Can MediciNova Inc continue delivering strong returnsMarket Activity Recap & Weekly Setup with ROI Potential - baoquankhu1.vn
Aug Analyst Calls: Can AACG be recession proofJuly 2025 Rallies & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
MediciNova (MNOV) Price Target Increased by 11.11% to 10.20 - Nasdaq
Breakout Watch: What analysts say about MediciNova Inc stockGDP Growth & Daily Growth Stock Investment Tips - baoquankhu1.vn
Market Moves: Can MediciNova Inc continue delivering strong returns2025 Stock Rankings & Risk Managed Trade Strategies - baoquankhu1.vn
MediciNova: Q4 Earnings Snapshot - Stamford Advocate
MediciNova, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
MediciNova (NASDAQ:MNOV) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
Aug PreEarnings: What analysts say about MediciNova Inc stockJuly 2025 Setups & Daily Profit Focused Stock Screening - baoquankhu1.vn
Can MediciNova Inc. continue delivering strong returnsJuly 2025 EndofMonth & Long-Term Safe Return Strategies - mfd.ru
MediciNova reports preliminary 2025 financial results in Tokyo filing By Investing.com - Investing.com India
MediciNova Financial Report: Q4 & Annual 2025 ResultsLoss & Revenue FiguresNews and Statistics - IndexBox
MediciNova reports preliminary 2025 financial results in Tokyo filing - Investing.com
4875.T MediciNova (JPX) JPY 254.00 pre-earnings 19 Feb: catalysts to watch - Meyka
MediciNova, Inc. (NASDAQ:MNOV) Short Interest Update - MarketBeat
MediciNova (MNOV) Projected to Post Earnings on Wednesday - MarketBeat
Does MediciNova Inc. have strong fundamentalsRisk Management & Fast Exit and Entry Trade Guides - mfd.ru
MNOV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Medicinova Inc (MNOV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):